Matrix metalloproteinase 3 messenger RNA 3'-untranslated region (MMP3 mRNA 3'-UTR) (MMP3 mRNA 3'-UTR)

The Matrix metalloproteinase 3 (MMP3) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the MMP3 transcript that governs the enzyme's expression through post-transcriptional mechanisms (PMID: 24603414). MMP3, also known as stromelysin-1, is a proteoglycanase capable of degrading various components of the extracellular matrix, including collagen types II, IV, IX, and X, as well as laminin and fibronectin (UniProt P08281). The 3'-UTR contains specific binding sites for microRNAs (miRNAs) such as miR-140 and miR-519d, which modulate mRNA stability and translational efficiency (PMID: 30106614). Dysregulation of MMP3 expression, often mediated by changes in 3'-UTR interactions, is a hallmark of degenerative joint diseases like osteoarthritis and rheumatoid arthritis, where excessive MMP3 leads to cartilage destruction (PMID: 21163941). Furthermore, MMP3 is implicated in cancer progression, facilitating tumor cell invasion and metastasis by degrading the basement membrane. Therapeutic strategies targeting the MMP3 mRNA 3'-UTR, such as miRNA mimics or antisense oligonucleotides, aim to reduce pathological MMP3 levels by promoting transcript degradation or inhibiting translation, thereby preserving tissue integrity in inflammatory and oncological contexts.

Other names

Stromelysin-1 mRNA 3'-UTRMMP-3 mRNA 3'-UTRMatrix metallopeptidase 3 mRNA 3'-UTRMMP3 3'-untranslated region

MicroRNA-mediated gene silencing and antisense-mediated mRNA degradation or translational repression targeting the 3'-UTR to reduce MMP3 protein expression.